Corcept Therapeutics | CORT - الربح الإجمالي على المبيعات





الربح الإجمالي على المبيعات تغيير تاريخ
Acadia Pharmaceuticals USD 243.27M 14.49M 2026-03
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
ANI Pharmaceuticals USD 124.18M 12.39M 2025-12
Ardelyx USD 89.66M 24.7M 2026-03
Aurora Cannabis CAD 29.79M 16.83M 2026-03
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Canopy Growth CAD 8.26M 13.2M 2026-03
Corcept Therapeutics USD 252.09M 90.07M 2026-06
Eli Lilly USD 15.92B 1.33B 2025-12
J&J USD 18.55B 1.31B 2026-06
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Lexicon Pharmaceuticals USD 5.29M 8.88M 2025-12
Merck USD 10.85B 2.57B 2025-12
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Novartis USD 11.24B 1.18B 2026-06
Novartis USD 10.07B 758M 2026-03
Omeros USD -33.16M 18.52M 2024-06
Pacira USD 126.64M 15.61M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Supernus Pharmaceuticals USD 129.36M 34.68M 2026-03
TG Therapeutics USD 171.41M 16.98M 2026-03